There is one summary for this bill. Bill summaries are authored by CRS.

Shown Here:
Introduced in Senate (07/19/2006)

Amends the Federal Food, Drug, and Cosmetic Act to prohibit a holder of a new, approved drug application from manufacturing, marketing, selling, or distributing a generic version of such drug during any exclusivity period granted to manufacturers of generic brands.